A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.

Published in:

Translational Psychiatry, 2016, v. 6, n. 11, p. e952, doi. 10.1038/tp.2016.194

By:

• Paterson, R W;
• Heywood, W E;
• Heslegrave, A J;
• Magdalinou, N K;
• Andreasson, U;
• Sirka, E;
• Bliss, E;
• Slattery, C F;
• Toombs, J;
• Svensson, J;
• Johansson, P;
• Fox, N C;
• Zetterberg, H;
• Mills, K;
• Schott, J M

Publication type:

Article